As a number of existing therapies are being re-purposed to help patients with the most severe Covid-19 symptoms, we speak to a UK-based bioscience company about a drug they've developed and explore how it is being used in Italy. Guests: Tom Whipple, The Times science editorSomeit Sidhu, CEO and Co-founder of Izana BioscienceHost: Manveen RanaThis podcast was brought to you thanks to subscribers of The Times and The Sunday Times. To enjoy unlimited digital access to all our journalism subscribe here. Hosted on Acast. See acast.com/privacy for more information.

Ver todos los episodios